======= CBX4 ======= == Gene Information == * **Official Symbol**: CBX4 * **Official Name**: chromobox 4 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8535|8535]] * **UniProt**: [[https://www.uniprot.org/uniprot/O00257|O00257]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CBX4&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CBX4|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603079|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: E3 SUMO-protein ligase which facilitates SUMO1 conjugation by UBE2I (PubMed:12679040). Involved in the sumoylation of HNRNPK, a p53/TP53 transcriptional coactivator, hence indirectly regulates p53/TP53 transcriptional activation resulting in p21/CDKN1A expression. Monosumoylates ZNF131 (PubMed:22825850). {ECO:0000269|PubMed:12679040, ECO:0000269|PubMed:22825850}. |Chromo| |SUMO binding| |SUMO transferase activity| |PRC1 complex| |PcG protein complex| |phosphoprotein binding| |single-stranded RNA binding| |methylated histone binding| |protein sumoylation| |transcription regulatory region DNA binding| |transcription corepressor activity| |nuclear body| |peptidyl-lysine modification| |enzyme binding| |chromatin binding| |nuclear speck| |chromatin organization| |protein modification by small protein conjugation| |negative regulation of transcription by RNA polymerase II| |peptidyl-amino acid modification| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |protein modification by small protein conjugation or removal| |negative regulation of cell death| |chromosome organization| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |regulation of apoptotic process| |negative regulation of biosynthetic process| |regulation of programmed cell death| |regulation of cell death| |negative regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp472|CI-1040 9.5μM R08 exp472]]|-2.56| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|-2.01| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|-1.92| |[[:results:exp539|42°C R08 exp539]]|-1.9| |[[:results:exp211|AICAR 240μM R05 exp211]]|-1.9| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|-1.86| |[[:results:exp496|Lead acetate 990μM R08 exp496]]|-1.86| |[[:results:exp34|Rotenone 20μM R00 exp34]]|-1.85| |[[:results:exp189|Temozolomide 200μM R04 exp189]]|1.75| |[[:results:exp41|BI-2536 0.001μM R01 exp41]]|1.92| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|2.82| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13913 * **Expression level (log2 read counts)**: 6.12 {{:chemogenomics:nalm6 dist.png?nolink |}}